SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

FARRELL PETER C

(Last)

(First)

(Middle)

RESMED INC.

9001 SPECTRUM CENTER BOULEVARD

(Street)

SAN DIEGO

92123

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
RESMED INC [ RMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/19/2020

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
ResMed Common Stock	11/19/2020		A⁽¹⁾		1,187	A	$0	228,636	D
ResMed Common Stock								0	I	Peter C. Farrell April 2010 Annuity Trust
ResMed Common Stock								200,000	I	Peter C. Farrell August 2011 Annuity Trust
ResMed Common Stock								0	I	Peter C. Farrell December 2009 Annuity Trust
ResMed Common Stock								200,000	I	Peter C. Farrell December 2010 Annuity Trust
ResMed Common Stock								0	I	Peter C. Farrell December 2011 Annuity Trust
ResMed Common Stock								200,000	I	Peter C. Farrell December 2012 Annuity Trust
ResMed Common Stock								0	I	Peter C. Farrell February 2012 Annuity Trust⁽²⁾
ResMed Common Stock								0	I	Peter C. Farrell Grantor Retained Annuity Trust dated December 2012⁽²⁾
ResMed Common Stock								200,000	I	Peter C. Farrell Grantor Retained Annuity Trust dated December 2012 Annuity Trust⁽³⁾
ResMed Common Stock								0	I	Peter C. Farrell Grantor Retained Annuity Trust dated March 4, 2014⁽²⁾⁽⁴⁾⁽⁵⁾
ResMed Common Stock								0	I	Peter C. Farrell Grantor Retained Annuity Trust dated October 14, 2014⁽²⁾⁽⁴⁾
ResMed Common Stock								22,783	I	Peter C. Farrell Grantor Retained Trust dated December 2012⁽²⁾
ResMed Common Stock								21,391	I	Peter C. Farrell July 2010 Annuity Trust
ResMed Common Stock								200,000	I	Peter C. Farrell November 2010 Annuity Trust⁽⁶⁾
ResMed Common Stock								0	I	Peter C. Farrell November 2010 Annuity Trusts

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Shares awarded are restricted stock units. The RSUs vest on the earlier of November 11, 2021, or the annual shareholders meeting in the year following the grant date.

2. Securities held by Larry Poster, Trustee of the Peter C. Farrell Grantor Retained Annuity Trust.

3. Securities held by Larry Poster, Trustee of the Peter C. Farrell Grantor Retained Annuity Trust dated December 2012.

4. Larry Poster is the Trustee of the GRAT.

5. Securities held by Larry Poster, Trustee of the Peter C. Farrell Grantor Retained Annuity Trust dated March 4, 2014.

6. Funded as a gift from the Peter C. Farrell Family Trust on November 15, 2010, with a distribution date of November 15, 2011.

	Peter C. Farrell, Chairman	11/20/2020
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.